3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
3
Phase 1
2
Phase 3
1
Phase 1/2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
60
Prostatic Neoplasms
52
Squamous Cell Carcinoma of Head and Neck
43
Carcinoma, Non-Small-Cell Lung
39
Head and Neck Neoplasms
37
Lung Neoplasms
35
Lymphoma
34
Leukemia
22
Brain Neoplasms
20
Central Nervous System Neoplasms
19
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Glioblastoma
18
Uterine Cervical Neoplasms
17
Sarcoma
17
Rectal Neoplasms
17
Lymphoma, Follicular
16
Esophageal Squamous Cell Carcinoma
16
Esophageal Neoplasms
15
Lymphoma, Large B-Cell, Diffuse
14
Hodgkin Disease
14
Burkitt Lymphoma
14
Adenocarcinoma of Lung
13
Oligodendroglioma
12
Lymphoma, Non-Hodgkin
12
Neoplasm Metastasis
11
Astrocytoma
11
Rhabdomyosarcoma
10
Lymphoma, Large-Cell, Immunoblastic
10
Neuroblastoma
9
Nasopharyngeal Carcinoma
9
Interventions
Sorafenib
8
durvalumab
4
Cisplatin
4
Gemcitabine
3
Ethiodized Oil
3
Doxorubicin
3
Chemotherapy, Adjuvant
3
Bevacizumab
3
tremelimumab
2
sodium thiosulfate
2
phosphomannopentaose sulfate
2
Watchful Waiting
2
Talaporfin
2
Radiofrequency Ablation
2
Oxaliplatin
2
Nivolumab
2
Folfox protocol
2
Celecoxib
2
Capecitabine
2
Analgesia, Patient-Controlled
2
seocalcitol
1
parecoxib
1
nolatrexed
1
linifanib
1
lenvatinib
1
ferumoxides
1
ferric carboxymaltose
1
contrast agent BR1
1
cabozantinib
1
brivanib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Liver Neoplasms
×
Radiotherapy
×
Clear all
NCT02125396
2023-01-27
ARTC-HCC
Guangxi Medical University
Phase 3
Unknown
150 enrolled